Treg

News

Mary Brunkow, Fred Ramsdell, and Shimon Sakaguchi

Regulatory T-cell scientist trio wins Nobel Prize

The Nobel Prize in Physiology or Medicine goes to three scientists for their work on regulatory T-cells, spawning hundreds of trials of new therapies.

R&D

Partner Content

7th Treg-Directed Therapies Summit

Unravelling Treg Biology, Pioneering Best-in-Class Approaches & Demonstrating Clinical Efficacy to Advance Validated Therapeutic Options in Autoimmunity, Inflammation & Beyond

News

AstraZeneca inks $2bn Treg cell therapy deal with Quell

UK start-up Quell Therapeutics has secured a partnership with AstraZeneca focused on cell therapies for autoimmune diseases, with an $85 million upfront payment and which

News

BMS adds to IBD pipeline with $1.9bn GentiBio deal

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD).

Events

Partner Content

4th Treg Directed Therapies Summit 2022

See the full potential of Treg therapies

Regulatory T-cell scientist trio wins Nobel Prize

7th Treg-Directed Therapies Summit

AstraZeneca inks $2bn Treg cell therapy deal with Quell

BMS adds to IBD pipeline with $1.9bn GentiBio deal

4th Treg Directed Therapies Summit 2022

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

Treg

Editor's Picks